| Product Name | MF | CAS | Details |
|---|
| 1-[1-(4-Bromophenyl)cyclopropyl]ethan-1-one | C11H11BrO | 1368556-46-0 | Details |
| 2-[3-(Aminomethyl)phenoxy]acetonitrile hydrochloride | C9H11ClN2O | 1306603-16-6 | Details |
| 4-Fluoro-3-nitrobenzaldehyde | C7H4FNO3 | 42564-51-2 | Details |
| N-(Pyridin-3-yl)piperidine-4-carboxamide dihydrochloride | C11H17Cl2N3O | 110106-25-7 | Details |
| Galectin 3 protein (His tag) | Details |
| 2,4,4-Trimethylpentan-1-ol | C8H18O | 16325-63-6 | Details |
| (Bromomethyl)phosphonic acid | CH4BrO3P | 7582-40-3 | Details |
| Difluprednate | C27H34F2O7 | 23674-86-4 | Details |
| (S)-1-Methylpyrrolidin-3-amine dihydrochloride | C5H14Cl2N2 | 874348-06-8 | Details |
| RBMX antibody | Details |
| 2-Amino-2-t-butylpropanoic acid HCl | C7H16ClNO2 | 88807-79-8 | Details |
| 2-(2-Methylpropyl)benzonitrile | C11H13N | 13670-97-8 | Details |
| H-GPLQLER-OH | Details |
| 4-Chloro-3-(morpholine-4-sulfonyl)-phenylamine | C10H13ClN2O3S | 325724-68-3 | Details |
| [(3r,3As,6Ar)-Hydroxyhexahydrofuro[2,3-b]furanyl succinimydyl carbonate | C11H13NO7 | 253265-97-3 | Details |
| (2,3-Dihydro-1,4-benzodioxin-5-yl)methanesulfonamide | C9H11NO4S | 1247227-63-9 | Details |
| 2,4-Dimethylbenzoic acid | C9H10O2 | 611-01-8 | Details |
| Ethyl 1-((4-chlorophenyl)sulfonyl)-4-piperidinecarboxylate | C14H18ClNO4S | 313685-03-9 | Details |
| Lachesine hydrochloride | C20H26ClNO3 | 1164-38-1 | Details |
| 7-Bromo-1-azatricyclo[7.3.1.0,5,13]trideca-5,7,9(13)-trien-2-one | C12H12BrNO | 57369-19-4 | Details |
| Ethylene Glycol Monovinyl Ether,stabilized with KOH | C4H8O2 | 764-48-7 | Details |
| Methyl 4,5-diamino-2-fluorobenzoate | C8H9FN2O2 | 936939-69-4 | Details |
| tert-Butyl 2-carbamothioyl-2,2-dimethylacetate | C9H17NO2S | 75235-67-5 | Details |
| 2-{1-[(tert-Butoxy)carbonyl]piperidin-2-yl}-2-hydroxyacetic acid | C12H21NO5 | 141403-97-6 | Details |
| 2-(4-Fluorophenyl)-1,3-oxazole-4-carboxylic acid | C10H6FNO3 | 927800-88-2 | Details |
| Antisense oligonucleotide | Details |
| (1-methyl-1H-indazol-7-yl)methanamine hydrochloride | C9H12ClN3 | 1810069-86-3 | Details |
| H-LGSSEVEQVQLVVDGVK^^-OH | Details |
| Belantamab | 2061894-48-0 | Details |
| 6-(Chloromethyl)-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione | C4H4ClN3O2 | 24753-63-7 | Details |
| 3-Vinylpyridine | C7H7N | 1121-55-7 | Details |
| Decarboxy ciprofloxacin | C16H18FN3O | 105394-83-0 | Details |
| Dihydroresveratrol 3-O-glucoside | C20H24O8 | 100432-87-9 | Details |
| 5-Benzyl-2-hydroxybenzoic acid | C14H12O3 | 4386-41-8 | Details |
| Angelic acid | C5H8O2 | 565-63-9 | Details |
| 4-(3-Chlorophenyl)-3-thiosemicarbazide | C7H8ClN3S | 42135-76-2 | Details |
| 3'-Hydroxyacetophenone | C8H8O2 | 121-71-1 | Details |
| 18-(Tert-butoxy)-18-oxooctadecanoic acid | C22H42O4 | 843666-40-0 | Details |
| N-(1-Hydroxy-2-oxo-2-phenylethyl)acetamide | C10H11NO3 | 2187-27-1 | Details |
| AT-527 | C24H35FN7O11PS | 2241337-84-6 | Details |
| 2,6-Dichloro-7-isopropylpurine | C8H8Cl2N4 | 953018-13-8 | Details |
| Difethialone | C31H23BrO2S | 104653-34-1 | Details |
| 2-(But-3-yn-1-yloxy)benzaldehyde | C11H10O2 | 390410-52-3 | Details |
| Cimlanod | C5H7NO4S | 1620330-72-4 | Details |
| 1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-3,3-dimethylpyrrolidine-2-carboxylic acid | C22H23NO4 | 1310680-20-6 | Details |
| 2-Methylthio-N6-threonylcarbamoyladenosine | C16H22N6O8S | 70333-82-3 | Details |
| Fmoc-[ring-D5]Phe-OH | C24H16D5NO4 | 225918-67-2 | Details |
| D-Galactopyranosyl thiosemicarbazide | C7H15N3O5S | 154634-26-1 | Details |
| Biotin-PEG2-Claudin-9 | Details |
| 2-Methylstyrene | C9H10 | 611-15-4 | Details |
| Parkin antibody (Ser131) | Details |
| Methyl 1-methyl-1,2,3,4-tetrahydroquinoline-4-carboxylate | C12H15NO2 | 1620079-56-2 | Details |
| Ginsenoside RS2 | C55H92O23 | 87733-66-2 | Details |
| H-S^LSLSLGK-OH | Details |
| Methyl 2,3-O-isopropylidene-β-D-ribofuranoside | C9H16O5 | 4099-85-8 | Details |
| Methyl 2,6-difluoro-3-(methylsulfamoyl)benzoate | C9H9F2NO4S | 1803580-83-7 | Details |
| 1-(Pyridin-4-yl)cyclohexane-1-carboxamide | C12H16N2O | 682739-20-4 | Details |
| 2-{4-[({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)methyl]-3,5-dimethyl-1H-pyrazol-1-yl}acetic acid | C23H23N3O4 | 2138370-76-8 | Details |
| 2-Amino-5-fluoro-4-methyl-N-(2,2,2-trifluoroethyl)benzamide | C10H10F4N2O | 1803589-94-7 | Details |
| Cyclohexylacetyl chloride | C8H13ClO | 23860-35-7 | Details |
| (3S,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol | C19H22O2 | 87095-75-8 | Details |
| 1-[3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl]ethan-1-amine hydrochloride | C10H11Cl2N3O | 1781933-01-4 | Details |
| 2-[3-(Trifluoromethyl)phenyl]morpholine | C11H12F3NO | 30914-89-7 | Details |
| 2-(2-Fluoro-3-nitrophenyl)acetic acid | C8H6FNO4 | 1214328-32-1 | Details |
| 2-[2,5-Dimethyl-1-(4-methylphenyl)-1H-pyrrol-3-yl]acetic acid | C15H17NO2 | 42779-84-0 | Details |
| 1,2,3,4,4a,9,9a,10-Octahydroacridine | C13H17N | 92039-20-8 | Details |
| (R)-6-Fluorospiro[chroman-2,1'-cyclobutan]-4-amine hydrochloride | 2227876-79-9 | Details |
| H-Thr-Tyr-Ser-OH | C16H23N3O7 | 81161-89-9 | Details |
| 2-Cyclohexylethane-1-sulfonamide | C8H17NO2S | 4378-98-7 | Details |
| 4-(Difluoromethyl)cycloheptan-1-one | C8H12F2O | 1803598-75-5 | Details |
| Dextrates | 39404-33-6 | Details |
| SIVmac239 - 36 | C73H116N22O21 | Details |
| 1-(3,4-Diethoxyphenyl)propan-1-one | C13H18O3 | 720-66-1 | Details |
| 4-(Ethylamino)-3-nitrobenzoic acid | C9H10N2O4 | 2788-74-1 | Details |
| Ethyl 6-Methyl-2-oxo-3-cyclohexene-1-carboxylate (mixture of isomers) | C10H14O3 | 3419-32-7 | Details |
| N-(5-Carboxypentyl)-deoxymannojirimycin hydrochloride | C12H23NO6 | 104154-10-1 | Details |
| Descyclopropyl lenvatinib | C18H15ClN4O4 | 417719-51-8 | Details |
| o-Phenylphenol glucuronide | C18H18O7 | 31016-74-7 | Details |
| 5-Fluoro-2-[2-(thiophen-2-yl)ethoxy]aniline | C12H12FNOS | 937596-85-5 | Details |
| RPC4 antibody | Details |
| 3-Amino-N-(4-chloro-phenyl)-4-morpholin-4-yl-benzenesulfonamide | C16H18ClN3O3S | 326916-21-6 | Details |
| PTGIS Blocking Peptide | Details |
| 2-{5-Methylthieno[2,3-b]thiophen-3-yl}acetic acid | C9H8O2S2 | 85504-38-7 | Details |
| CD248 antibody | Details |
| D-[UL-13C6]Glucosamine HCl | Details |
| Parietal Cell ELISA kit | Details |
| [5-Fluoro-2-(oxan-2-ylmethoxy)phenyl]boronic acid | C12H16BFO4 | 1311146-36-7 | Details |
| Ethyl 2-(cyclopropylamino)-4-methyl-1,3-thiazole-5-carboxylate hydrochloride | C10H15ClN2O2S | 1269152-06-8 | Details |
| 3-Hydroxy-7,2',4',5'-tetramethoxyflavone | C19H18O7 | 1017060-55-7 | Details |
| 3-Bromo-N-(pyridin-3-yl)benzamide | C12H9BrN2O | 349405-43-2 | Details |
| Monosialyl, monofucosyllacto-N-hexaose I | Details |
| FTL protein | Details |
| (1R)-1-Cycloheptylethan-1-ol | C9H18O | 1225478-35-2 | Details |
| Kininogen 1 antibody | Details |
| 2-(2,2-Dimethylpyrrolidin-3-yl)acetic acid hydrochloride | C8H15NO2.ClH | 2253629-89-7 | Details |
| Cyclin M4 Blocking Peptide | Details |
| 2,2',4,6'-Tetramethylbenzophenone | C17H18O | 22682-43-5 | Details |
| [1,2,4]Triazolo[4,3-a]pyridin-7-amine HCl | C6H7ClN4 | 1598386-14-1 | Details |
| Methyl 2-(benzyloxy)-5-chloro-4-methylbenzoate | C16H15ClO3 | 1461708-15-5 | Details |
| 3-Cyclohexyl-4-(2-methylpropyl)-1,2-oxazol-5-amine | C13H22N2O | 1250480-94-4 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||